{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:23:21Z","timestamp":1789352601846,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,20]],"date-time":"2006-02-20T00:00:00Z","timestamp":1140393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2006,2,20]],"date-time":"2006-02-20T00:00:00Z","timestamp":1140393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Chemokines are a superfamily of small peptides involved in leukocyte chemotaxis and in the induction of cytokines in a wide range of infectious diseases. Little is known about their role in meningococcal sepsis in children and their relationship with disease severity and outcome.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP) 1\u03b1, growth-related gene product (GRO)-\u03b1 and interleukin (IL)-8 were measured in 58 children with meningococcal sepsis or septic shock on admission and 24 hours thereafter. Nine patients died. Serum chemokine levels of survivors and nonsurvivors were compared, and the chemokine levels were correlated with prognostic disease severity scores and various laboratory parameters.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Extremely high levels of all chemokines were measured in the children's acute-phase sera. These levels were significantly higher in nonsurvivors compared with survivors and in patients with septic shock compared with patients with sepsis (<jats:italic>P<\/jats:italic> &lt; 0.0001). The cutoff values of 65,407 pg\/ml, 85,427 pg\/ml and 460 pg\/ml for monocyte chemoattractant protein, for IL-8 and for macrophage inflammatory protein 1\u03b1, respectively, all had 100% sensitivity and 94\u201398% specificity for nonsurvival. Chemokine levels correlated better with disease outcome and severity than tumor necrosis factor (TNF)-\u03b1 and correlated similarly to interleukin (IL)-6. In available samples 24 hours after admission, a dramatic decrease of chemokine levels was seen.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Initial-phase serum levels of chemokines in patients with meningococcal sepsis can predict mortality and can correlate strongly with disease severity. Chemokines may play a key role in the pathophysiology of meningococcal disease and are potentially new targets for therapeutic approaches.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc4836","type":"journal-article","created":{"date-parts":[[2006,2,24]],"date-time":"2006-02-24T07:31:20Z","timestamp":1140766280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity"],"prefix":"10.1186","volume":"10","author":[{"given":"Clementien L","family":"Vermont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A","family":"Hazelzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester D","family":"de Kleijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germie PJM","family":"van den Dobbelsteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald de","family":"Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,20]]},"reference":[{"key":"4367_CR1","first-page":"1861","volume":"150","author":"NW Lukacs","year":"1997","unstructured":"Lukacs NW, Chensue SW, Karpus WJ, Lincoln P, Keefer C, Strieter RM, Kunkel SL: C-C chemokines differentially alter interleukin-4 production from lymphocytes.\n                           Am J Pathol 1997, 150: 1861-1868.","journal-title":"Am J Pathol"},{"key":"4367_CR2","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.4049\/jimmunol.148.9.2764","volume":"148","author":"TJ Fahey 3rd","year":"1992","unstructured":"Fahey TJ 3rd, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, Cerami A, Sherry B: Macrophage inflammatory protein 1 modulates macrophage function.\n                           J Immunol 1992, 148: 2764-2769.","journal-title":"J Immunol"},{"key":"4367_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/84298","volume":"2","author":"CR Mackay","year":"2001","unstructured":"Mackay CR: Chemokines: immunology's high impact factors.\n                           Nat Immunol 2001, 2: 95-101. 10.1038\/84298","journal-title":"Nat Immunol"},{"key":"4367_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster AD: Chemokines \u2013 chemotactic cytokines that mediate inflammation.\n                           N Engl J Med 1998, 338: 436-445. 10.1056\/NEJM199802123380706","journal-title":"N Engl J Med"},{"key":"4367_CR5","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/blood.V90.3.909","volume":"90","author":"BJ Rollins","year":"1997","unstructured":"Rollins BJ: Chemokines.\n                           Blood 1997, 90: 909-928.","journal-title":"Blood"},{"key":"4367_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","volume":"188","author":"AM Fong","year":"1998","unstructured":"Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel DD: Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.\n                           J Exp Med 1998, 188: 1413-1419. 10.1084\/jem.188.8.1413","journal-title":"J Exp Med"},{"key":"4367_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.155.1.203","volume":"155","author":"J Kennedy","year":"1995","unstructured":"Kennedy J, Kelner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV, Cocks BG, Bacon KB, Zlotnik A: Molecular cloning and functional characterization of human lymphotactin.\n                           J Immunol 1995, 155: 203-209.","journal-title":"J Immunol"},{"key":"4367_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/76957","volume":"1","author":"J Aliberti","year":"2000","unstructured":"Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, Sher A: CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells.\n                           Nat Immunol 2000, 1: 83-87. 10.1038\/76957","journal-title":"Nat Immunol"},{"key":"4367_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/rmv.369","volume":"13","author":"K Kedzierska","year":"2003","unstructured":"Kedzierska K, Crowe SM, Turville S, Cunningham AL: The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.\n                           Rev Med Virol 2003, 13: 39-56. 10.1002\/rmv.369","journal-title":"Rev Med Virol"},{"key":"4367_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1365-2249.1998.00698.x","volume":"114","author":"CM Mastroianni","year":"1998","unstructured":"Mastroianni CM, Lancella L, Mengoni F, Lichtner M, Santopadre P, D'Agostino C, Ticca F, Vullo V: Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis.\n                           Clin Exp Immunol 1998, 114: 210-214. 10.1046\/j.1365-2249.1998.00698.x","journal-title":"Clin Exp Immunol"},{"key":"4367_CR11","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4049\/jimmunol.158.4.1956","volume":"158","author":"KS Spanaus","year":"1997","unstructured":"Spanaus KS, Nadal D, Pfister HW, Seebach J, Widmer U, Frei K, Gloor S, Fontana A: C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells\n                           in vitro\n                           .\n                           J Immunol 1997, 158: 1956-1964.","journal-title":"J Immunol"},{"key":"4367_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/clin.1996.0109","volume":"80","author":"H Sprenger","year":"1996","unstructured":"Sprenger H, Rosler A, Tonn P, Braune HJ, Huffmann G, Gemsa D: Chemokines in the cerebrospinal fluid of patients with meningitis.\n                           Clin Immunol Immunopathol 1996, 80: 155-161. 10.1006\/clin.1996.0109","journal-title":"Clin Immunol Immunopathol"},{"key":"4367_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-5728(97)00267-1","volume":"85","author":"F Lahrtz","year":"1998","unstructured":"Lahrtz F, Piali L, Spanaus KS, Seebach J, Fontana A: Chemokines and chemotaxis of leukocytes in infectious meningitis.\n                           J Neuroimmunol 1998, 85: 33-43. 10.1016\/S0165-5728(97)00267-1","journal-title":"J Neuroimmunol"},{"key":"4367_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/infdis\/167.2.471","volume":"167","author":"A Halstensen","year":"1993","unstructured":"Halstensen A, Ceska M, Brandtzaeg P, Redl H, Naess A, Waage A: Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease.\n                           J Infect Dis 1993, 167: 471-475.","journal-title":"J Infect Dis"},{"key":"4367_CR15","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/infdis\/173.5.1148","volume":"173","author":"RF Kornelisse","year":"1996","unstructured":"Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, Risseeuw-Appel IM, van der Voort E, de Groot R: The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.\n                           J Infect Dis 1996, 173: 1148-1156.","journal-title":"J Infect Dis"},{"key":"4367_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1086\/315680","volume":"182","author":"ED Carrol","year":"2000","unstructured":"Carrol ED, Thomson AP, Mobbs KJ, Hart CA: The role of RANTES in meningococcal disease.\n                           J Infect Dis 2000, 182: 363-366. 10.1086\/315680","journal-title":"J Infect Dis"},{"key":"4367_CR17","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.\n                           Crit Care Med 2003, 31: 1250-1256. 10.1097\/01.CCM.0000050454.01978.3B","journal-title":"Crit Care Med"},{"key":"4367_CR18","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1097\/01.CCM.0000072121.61120.D8","volume":"31","author":"ED de Kleijn","year":"2003","unstructured":"de Kleijn ED, de Groot R, Hack CE, Mulder PG, Engl W, Moritz B, Joosten KF, Hazelzet JA: Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.\n                           Crit Care Med 2003, 31: 1839-1847. 10.1097\/01.CCM.0000072121.61120.D8","journal-title":"Crit Care Med"},{"key":"4367_CR19","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.\n                           Thromb Haemost 2001, 86: 1327-1330.","journal-title":"Thromb Haemost"},{"key":"4367_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.\n                           Intensive Care Med 1996, 22: 707-710.","journal-title":"Intensive Care Med"},{"key":"4367_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/00003246-198811000-00006","volume":"16","author":"MM Pollack","year":"1988","unstructured":"Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score.\n                           Crit Care Med 1988, 16: 1110-1116.","journal-title":"Crit Care Med"},{"key":"4367_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0952-7915(01)00308-9","volume":"14","author":"AD Luster","year":"2002","unstructured":"Luster AD: The role of chemokines in linking innate and adaptive immunity.\n                           Curr Opin Immunol 2002, 14: 129-135. 10.1016\/S0952-7915(01)00308-9","journal-title":"Curr Opin Immunol"},{"key":"4367_CR23","first-page":"76","volume":"10","author":"S Schinkel","year":"2005","unstructured":"Schinkel S, Schinkel C, Pollard V, Garofallo R, Heberle H, Reisner P, Papaconstantinou J, Herndon DN: Effects of endotoxin on serum chemokines in man.\n                           Eur J Med Res 2005, 10: 76-80.","journal-title":"Eur J Med Res"},{"key":"4367_CR24","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/BF01709331","volume":"22","author":"S Fujishima","year":"1996","unstructured":"Fujishima S, Sasaki J, Shinozawa Y, Takuma K, Kimura H, Suzuki M, Kanazawa M, Hori S, Aikawa N: Serum MIP-1 alpha and IL-8 in septic patients.\n                           Intensive Care Med 1996, 22: 1169-1175.","journal-title":"Intensive Care Med"},{"key":"4367_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1086\/427514","volume":"191","author":"AS M\u00f8ller","year":"2005","unstructured":"M\u00f8ller AS, Bjerre A, Brusletto B, Joo GB, Brandtzaeg P, Kierulf P: Chemokine patterns in meningococcal disease.\n                           J Infect Dis 2005, 191: 768-775. 10.1086\/427514","journal-title":"J Infect Dis"},{"key":"4367_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1084\/jem.169.1.333","volume":"169","author":"A Waage","year":"1989","unstructured":"Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.\n                           J Exp Med 1989, 169: 333-338. 10.1084\/jem.169.1.333","journal-title":"J Exp Med"},{"key":"4367_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/infdis\/172.2.433","volume":"172","author":"M van Deuren","year":"1995","unstructured":"van Deuren M, van der Ven-Jongekrijg J, Bartelink AK, van Dalen R, Sauerwein RW, van der Meer JW: Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.\n                           J Infect Dis 1995, 172: 433-439.","journal-title":"J Infect Dis"},{"key":"4367_CR28","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/thorax.55.12.1023","volume":"55","author":"J Hull","year":"2000","unstructured":"Hull J, Thomson A, Kwiatkowski D: Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families.\n                           Thorax 2000, 55: 1023-1027. 10.1136\/thorax.55.12.1023","journal-title":"Thorax"},{"key":"4367_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1006\/bbrc.1999.0796","volume":"259","author":"BH Rovin","year":"1999","unstructured":"Rovin BH, Lu L, Saxena R: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.\n                           Biochem Biophys Res Commun 1999, 259: 344-348. 10.1006\/bbrc.1999.0796","journal-title":"Biochem Biophys Res Commun"},{"key":"4367_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/sj.gene.6363759","volume":"2","author":"X Xin","year":"2001","unstructured":"Xin X, Nakamura K, Liu H, Nakayama EE, Goto M, Nagai Y, Kitamura Y, Shioda T, Iwamoto A: Novel polymorphisms in human macrophage inflammatory protein-1 alpha (MIP-1alpha) gene.\n                           Genes Immun 2001, 2: 156-158. 10.1038\/sj.gene.6363759","journal-title":"Genes Immun"},{"key":"4367_CR31","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2174\/1381612033454937","volume":"9","author":"T Saeki","year":"2003","unstructured":"Saeki T, Naya A: CCR1 chemokine receptor antagonist.\n                           Curr Pharm Des 2003, 9: 1201-1208. 10.2174\/1381612033454937","journal-title":"Curr Pharm Des"},{"key":"4367_CR32","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0006-2952(02)01626-X","volume":"65","author":"DJ Grainger","year":"2003","unstructured":"Grainger DJ, Reckless J: Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects\n                           in vivo\n                           .\n                           Biochem Pharmacol 2003, 65: 1027-1034. 10.1016\/S0006-2952(02)01626-X","journal-title":"Biochem Pharmacol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc4836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc4836\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc4836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:54:32Z","timestamp":1728305672000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc4836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,2]]}},"alternative-id":["4367"],"URL":"https:\/\/doi.org\/10.1186\/cc4836","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,20]]},"assertion":[{"value":"9 December 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R33"}}